SOP for Analytical Method Validation

-

STANDARD OPERATING PROCEDURE

Analytical Method Validation

SOP No.QC/AMV/001 Version1.0
Effective Date________ Review Date________

1. PURPOSE

To describe the procedure for validation of analytical methods to demonstrate that the method is suitable for its intended purpose and generates reliable, accurate, and reproducible results in accordance with pharmacopoeial and regulatory requirements.

2. SCOPE

This SOP applies to validation of analytical procedures used for assay, organic impurities (related substances), and dissolution testing of pharmaceutical products performed in the Quality Control laboratory.

3. REGULATORY REFERENCES

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <1225> – Validation of Compendial Procedures
  • General chapters and notices of IP, BP, and EP

4. RESPONSIBILITIES

  • QC Analyst: Execution of validation and documentation of data
  • QC Reviewer: Review of raw data and calculations
  • QC Head: Approval of validation report
  • Quality Assurance: Final approval and archival

5. GENERAL REQUIREMENTS

  • Analytical instruments shall be calibrated and qualified.
  • Reference standards shall be qualified and within validity.
  • System suitability criteria shall be met prior to analysis.
  • All records shall comply with Good Documentation Practices.

6. STANDARD & SAMPLE PREPARATION

6.1 Standard Solution Preparation

  1. Accurately weigh the required quantity of reference standard.
  2. Dissolve in suitable diluent as specified in the analytical method.
  3. Sonicate if necessary and make up to volume.
  4. Further dilute to obtain working standard concentration.
  5. Prepare fresh unless stability is established.

6.2 Sample Solution Preparation

  1. Accurately weigh or measure sample equivalent to labeled claim.
  2. Add specified diluent and extract the analyte.
  3. Sonicate or shake as required.
  4. Make up to volume and filter if applicable.
  5. Prepare individual sample preparations where required.

7. VALIDATION PROCEDURE

7.1 Assay Method Validation

  • Specificity: Inject blank, placebo, standard, and sample (1 injection each).
  • Precision: Six (6) independent sample preparations; one injection each.
  • Intermediate Precision: Six (6) sample preparations on different day/analyst.
  • Accuracy: 80%, 100%, 120%; three (3) replicates per level (9 injections).
  • Linearity: Minimum five (5) concentration levels; one injection per level.

7.2 Organic Impurities (Related Substances)

  • Specificity: Inject blank, placebo, impurity standards, spiked sample, and sample.
  • System Precision: Six (6) injections of standard solution.
  • Method Precision: Six (6) individual sample preparations.
  • LOD: Signal-to-noise approach or calibration curve.
  • LOQ Precision: Six (6) injections at LOQ level.
  • Accuracy: LOQ, 50%, 100%, 150%; three (3) replicates per level.
  • Linearity: Minimum five (5) levels from LOQ to 150%.

7.3 Dissolution Method Validation

  • Precision: Six (6) individual dosage units.
  • Intermediate Precision: Six (6) units on different day/analyst.
  • Accuracy: 80%, 100%, 120%; three (3) units per level.
  • Linearity (if applicable): Five (5) concentration levels.

8. ACCEPTANCE CRITERIA

8.1 Assay

  • Specificity: No interference at analyte retention time.
  • Precision: %RSD ≤ 2.0%.
  • Intermediate Precision: %RSD ≤ 3.0%.
  • Accuracy: Mean recovery 98.0% – 102.0%.
  • Linearity: Correlation coefficient (r) ≥ 0.999.

8.2 Organic Impurities

  • System Precision: %RSD ≤ 5.0%.
  • Method Precision: %RSD ≤ 10.0%.
  • LOD: Signal-to-noise ≥ 3:1.
  • LOQ: Signal-to-noise ≥ 10:1.
  • Accuracy: Mean recovery 80.0% – 120.0%.
  • Linearity: Correlation coefficient (r) ≥ 0.99.

8.3 Dissolution

  • Precision: %RSD ≤ 10.0%.
  • Intermediate Precision: %RSD ≤ 15.0%.
  • Accuracy: Mean recovery 95.0% – 105.0%.
  • Linearity (if applicable): r ≥ 0.999.

Note: Acceptance criteria may be adjusted based on method type, concentration level, and scientific justification documented in the validation protocol.

9. ROBUSTNESS

Evaluate the effect of small deliberate changes in method parameters (e.g., flow rate, pH, wavelength, temperature) on method performance.

10. VALIDATION REPORT

A validation report shall summarize experiments, results, statistical evaluation, deviations, and conclusion on method suitability.

11. REVALIDATION

Revalidation shall be performed following changes in method, equipment, formulation, or regulatory requirements.

12. REVISION HISTORY

VersionDateReason
1.0________Initial Issue

Comments

Post a Comment

Popular posts from this blog

-
⚠️SOP for Risk Management and Risk Assessment (FMEA, RPN, HAZOP, SWOT) This Standard Operating Procedure (SOP) describes a comprehensive risk management and risk assessment framework using FMEA, RPN, HAZOP, and SWOT methodologies. It supports pharmaceutical quality systems in accordance with ICH Q9 and ISO 31000 for effective identification, evaluation, mitigation, and monitoring of risks. 1. Introduction Risk Management is a structured approach to identify, assess, mitigate, and monitor risks in laboratory, R&D, QC, manufacturing, and quality systems. This SOP provides step-by-step instructions for multiple risk assessment techniques, including FMEA, RPN, HAZOP, and SWOT analysis, ensuring robust evaluation, prioritization, and mitigation of risks. 2. Purpose To establish a standardized framework for risk identification, analysis, evaluation, mitigation, monitoring, and continuous improvement using multiple validated risk assessment techniques, ens...
Read more

SOP for Operation and Calibration of UV-Visible Spectrophotometer

-
SOP for UV-Visible Spectrophotometer Operation & Calibration SOP for UV-Visible Spectrophotometer Operation & Calibration SOP Code: [Assign Code] Version: 1.0 Effective Date: [Insert Date] Review Date: [Insert Date] Prepared by: [Name / Designation] Approved by: [Name / Designation] 1. Purpose To provide detailed instructions for safe operation, calibration, and verification of UV-Visible spectrophotometers in compliance with IP, USP, BP, and EP standards to ensure accurate and reliable analytical results. 2. Scope This SOP applies to all analysts and QC personnel performing routine or validation analysis using UV-Visible spectrophotometers. 3. Responsibilities Role Responsibility Analyst / Technician Operate the instrument, prepare standards, perform calibration, and record results. QC / QA Officer Review and approve calibration logs, ensure compliance with pharmacopeial requirements. Maintenance Personnel Perform preventiv...
Read more

Operation and Calibration of Tap Density Apparatus

-
Operation and Calibration of Tap Density Apparatus 1. Purpose To establish a standardized and detailed procedure for the operation, calibration, and maintenance of the Tap Density Apparatus used for determination of bulk density and tapped density of powders, granules, and solid materials in accordance with pharmacopeial and GMP requirements. 2. Scope Quality Control laboratories Research and Development laboratories Production and in-process testing laboratories Any department performing bulk and tap density analysis 3. Definitions Bulk Density: Mass of powder divided by its untapped volume. Tapped Density: Mass of powder divided by the volume after mechanical tapping. Tap Density Apparatus: Instrument that mechanically taps a graduated cylinder to obtain reproducible tapped volume. Carr’s Index: Measure of compressibility calculated from bulk and tapped density. Hausner Ratio: Ratio of tapped density to bulk density. ...
Read more